1. Axelrod, J., 1954, Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine, J. Pharmacol. Exp. Ther., 110: 315.
2. Bennett, J. P., Jr., and Snyder, S. H., 1976, Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors, Mol. Pharmacol., 12: 373.
3. Clineschmidt, B. V., McGuffin, J. C., and Pflueger, A. B., 1977, Central serotonin-like activity of 6-chloro-2[l-piperazinyl]-pyrazine (CPP: MK-212), Eur. J. Pharmacol., 44: 65.
4. Clineschmidt, B. V., Totaro, J. A., Pflueger, A. B., and McGuffin, J. C., 1978, Inhibition of the serotoninergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]pyrazine), Pharmacol. Res. Commun., 10: 219.
5. Fuller, R. W., and Clemens, J. A., 1979, 1-(m-Trifluoromethylphenyl)-piperazine, a serotonin agonist, increases serum corticosterone and prolactin concentration in rats, IRCS Med. Sci., 7: 106.